SQ Innovation: 86% of Heart Failure Patients Decongested at Home
Burlington – October 12, 2026 -- Eighty-six percent of 21 heart failure patients at imminent risk of hospital admission were decongested at home without hospitalization using SQ Innovation's subcutaneous furosemide product Lasix ONYU, according to interim results from the investigator-sponsored Gator SCALES-WHF study.
Three patients were admitted within 30 days for additional treatment. The data were presented on October 11 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026 in Phoenix, Arizona.
University of Florida study tests same-day home treatment pathway
Gator SCALES-WHF is a prospective, open-label, single-arm, real-world study at the University of Florida in Gainesville. Principal Investigator Mustafa M. Ahmed, MD, leads the trial, and cardiology fellow Jude ElSaygh, MD, presented the interim data.